Continuing Medical Education
Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, shares advances in cancer research and treatment with the healthcare community through continuing medical education (CME) courses.
Dana-Farber CME courses, offered in conjunction with Harvard Medical School or Partners HealthCare Office of Continuing Professional Development, which are both accredited by the Accreditation Council for Continuing Medical Education (ACCME), provide continuing medical education for physicians. These educational activities have been designated as credit towards the AMA Physician's Recognition Award.
Upcoming Courses
Cancer Immunotherapy: From Bench to Bedside and Back
June 10-12, 2024
This meeting will bring together experts from across the cancer immunotherapy field to present the most striking biological, technological, translational and clinical advances. Discussions will focus on how fundamental knowledge can be translated to the clinic, with insights gained in the clinical setting brought back to the lab to inform the development of innovative cancer immunotherapy approaches for the benefit a wider group of patients.
Breast Cancer: New Horizons, Current Controversies
July 11-12, 2024
Course Format: In Person and Live Virtual
Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease, improvements in diagnostic methods, treatment innovations, and management of breast cancer survivors.
4th Annual Update in Neuro-Oncology
July 24-26, 2024
This three-day CME course, Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors and neurological complications of cancer.
Grand Rounds
Dana-Farber is a teaching affiliate of Harvard Medical School and founder of Dana-Farber/Harvard Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute.
Visit our calendar of on-site educational opportunities for healthcare professionals, researchers and scientists, available through Dana-Farber and partnering institutions.